Inventor · disambiguated record
Jeffrey R. Spencer
Also filed as: SPENCER JEFFREY R
8 granted patents·4 pending applications·49 citations·filing 1995–2013
85Inventor score
Top patents by PatentIndex Score
12 records- 0187US6562854B2Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disordersAXYS PHARM INC·Filed 2001·Granted May 13, 2003·19 cites·16 claims
- 0279US7786159B2Thrombopoietin mimeticsSTATEGICS INC·Filed 2007·Granted Aug 31, 2010·4 cites·12 claims
- 0379US6861419B2Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2001·Granted Mar 1, 2005·12 cites·40 claims
- 0468US9163027B2Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survivalSTATEGICS INC·Filed 2013·Granted Oct 20, 2015·2 cites·43 claims
- 0568US8143287B2Thrombopoietin mimeticsSPENCER JEFFREY R·Filed 2010·Granted Mar 27, 2012·2 cites·46 claims
- 0663US9657024B2Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survivalSTATEGICS INC·Filed 2013·Granted May 23, 2017·1 cites·36 claims
- 0751US5994502AInhibitors of oligosaccharyl transferaseFiled 1997·Granted Nov 30, 1999·5 cites·4 claims
- 0846US2003212120A1Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disordersAXYS PHARM INC·Filed 2003·Application pending·0 cites
- 0937US2003232789A1Salicylamides as serine protease and factor xa inhibitorsFiled 2000·Application pending·0 cites
- 1037US2005026929A1Novel phenyl derivatives as inducers of apoptosisAXYS PHARM INC·Filed 2003·Application pending·0 cites
- 1136US5721338AInhibitors of oligosaccharyl transferaseCALIFORNIA INST OF TECHN·Filed 1995·Granted Feb 24, 1998·4 cites·18 claims
- 1235US2002052343A1Salicylamides as serine protease inhibitorsFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey R. Spencer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →